Axa S.A. Revelation Biosciences, Inc. Transaction History

Axa S.A.

  • $33.1 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Feb 14, 2023
BUY
$971.04 - $11077.5 $1.9 Billion - $21.7 Billion
1,958,984 New
1,958,984 $0

Others Institutions Holding REVB

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About REVELATION BIOSCIENCES, INC.

REVB Quotes by TradingView
  • Ticker REVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,525,800
  • Market Cap $20M
  • Description
  • Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...
More about REVB
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email